Demineralized Bone Matrix Market
Number of pages: 100 | Report Format: PDF | Published date: September 08, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market size value in 2021 |
USD 620 million |
|
Revenue forecast in 2030 |
USD 874.84 million |
|
Growth Rate |
CAGR of 3.9% from 2022 to 2030 |
|
Base year for estimation |
2021 |
|
Forecast period |
2022-2030 |
|
Segments covered |
Product Type, Application, End-User, and Region. |
|
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The global demineralized bone matrix market was pegged at US$ 620 million in 2021 and is expected to witness a CAGR of 3.9% during the forecast period.
Market Fundamentals
A commercial biomaterial that is both osteoconductive and osteoinductive is a demineralized bone matrix (DBM). It has a lengthy history of clinical use in a variety of forms and is a recognized medical device for the treatment of bone abnormalities. Acid extraction of allograft bone is used to create demineralized bone matrices, which results in the loss of most of the mineralized component but the retention of collagen and non-collagenous proteins, such as growth factors. The bone graft is lengthened and strengthened using a demineralized bone matrix. This is a result of growth factors' capacity to regulate the differentiation of progenitor cells, which oversee producing bone and cartilage.
Market Dynamic
[453627]
Over the course of the projection period, it is anticipated that the prevalence of orthopedic disorders will spur market expansion. The advantages of osteoinductivity and osteoconductive with a much lower complication rate offered by demineralized bone matrices open the market. Additionally, recent industry growth has been greatly influenced by technological developments such as the creation of biomimetic and implantable microcarriers using a demineralized bone matrix that maintains the essential biochemical composition, architecture, and surface topography of natural bone tissue.
However, the market may be hampered by the expensive price of a demineralized bone matrix due to complex manufacturing processes.
Market Ecosystem
The global demineralized bone matrix market has been analyzed from four perspectives: product type, application, end-user, and region.
Demineralized bone matrix Market by Product Type
Based on product type, the global demineralized bone matrix market is subdivided into putty and gel. The putty segment dominates the market due to the adoption of these products in orthopedic and dental disorders, as a supportive treatment. Wherein, the gel segment is expected to surge in the forecast period because of its biocompatible nature, and because it can be used in craniomaxillofacial and aesthetic surgeries.
Demineralized bone matrix Market by Application
[897563]
Based on the application, the global demineralized bone matrix market has been divided into, long bone procedure, spinal fusion, dental, craniomaxillofacial, joint reconstruction, and others. Through the projection period, the spinal fusion segment is predicted to experience a significant growth rate. Spinal fusion is used to fix problems with the spine's vertebrae. Demineralized bone matrices are being used as the preferred treatment for these spinal abnormalities to solve this issue. Therefore, it is predicted that over the course of the projection period, the revenue for the segment would increase due to the rising prevalence of older populations suffering from these spinal illnesses and the rising acceptance of demineralized bone matrix operations as a form of treatment.
Demineralized bone matrix Market by End User
Based on the end-user the global demineralized bone matrix market is divided into, hospitals and specialty clinics. The hospital segment dominates the market due to the presence of advanced types of equipment to perform highly complicated surgeries. Also, because of the high number of bone graft procedures taking place at the hospital. A rise in medical tourism is also one of the factors driving this segment.
Demineralized bone matrix Market by Region
Based on region, the global demineralized bone matrix market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. The largest market share was obtained by North America. The availability of modern healthcare infrastructure, increased healthcare spending, and awareness of commercially available products are the main drivers of its expansion. Due to the high prevalence of orthopedic disorders and trauma-related injuries, the U.S. in particular is driving the global market by creating the highest level of product demand. These elements support the segment's domination during the predicted period.
Competitive Landscape
Some of the prominent players operating in the global demineralized bone matrix market are:
Strategic Developments
The global demineralized bone matrix market is expected to grow at a CAGR of 3.9% in the forecast period.
Rising cases of spinal fusion and orthopedic surgeries, are governing the Demineralized bone matrix market.
Zimmer, Medtronic, Stryker Corp., etc are a few key players in the global demineralized bone matrix market.
The spinal fusion segment dominates the global DBM market, and the dental surgeries segment is expected to grow in the upcoming years.
Asia Pacific region is expected to witness the highest growth in the demineralized bone matrix market in the forecast period.
*Insights on financial permanence is subject to availability of information in public domain